7-(Ethylsulfonyl)-2-(piperidin-2-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-ol hydrochloride

Catalog No. :
ACOITA463
CAS No. :
1185297-74-8
Molecular Formula :
C14H23ClN4O3S
Molecular Weight :
362.88

IUPAC Name:7-(ethylsulfonyl)-2-(piperidin-2-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one hydrochloride

7-(Ethylsulfonyl)-2-(piperidin-2-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$676.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(Ethylsulfonyl)-2-(piperidin-2-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-ol hydrochloride
IUPAC Name7-(ethylsulfonyl)-2-(piperidin-2-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one hydrochloride
MDL No.MFCD12028556
Molecular FormulaC14H23ClN4O3S
Molecular Weight362.88
SMILESOC1=C2C(CN(S(=O)(CC)=O)CC2)=NC(C3NCCCC3)=N1.[H]Cl
InChI KeyDDJKPLZRVCQOSC-UHFFFAOYSA-N
Synonym7-Ethanesulfonyl-2-piperidin-2-yl-5,6,7,8-tetra-hydro-pyrido[3,4-d]pyrimidin-4-ol hydrochloride;7-Ethanesulfonyl-2-piperidin-2-yl-5,6,7,8-tetra-hydro-pyrido[3,4-d]pyrimidin-4-ol hydrochlorid
CAS No.1185297-74-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOITA463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOITA463 route product structure diagram
    ACOITA4631185297-74-8
Inquiry

2. ACOITA463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOITA463 route product structure diagram
    ACOITA4631185297-74-8
Inquiry

Comments (0)